Taken together these results indicate that suppression of GPC1 expression both with CRISPR/Cas9GPC1 and siRNAGPC1 attenuates progression of T24, U87 and HepG2 cancers by inhibiting cell proliferation. The gene discussed is GPC1; the disease is cancer.